Read this case study to learn how T2Candida enabled the detection of candidemia 29 hours before a positive blood culture was returned, allowing for the rapid initiation of targeted antifungal therapy in a critically ill COVID-19 patient.

Secondary Candidemia in Critically Ill COVID-19 Patient
T2Candida enabled the detection of candidemia 29 hours before a positive blood culture was returned. Early detection allowed for the rapid initiation of antifungal therapy in a critically ill COVID-19 patient.